BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ko S, Okano E, Kanehiro H, Matsumoto M, Ishizashi H, Uemura M, Fujimura Y, Tanaka K, Nakajima Y. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases. Liver Transpl. 2006;12:859-869. [PMID: 16528712 DOI: 10.1002/lt.20733] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Kume Y, Ikeda H, Inoue M, Tejima K, Tomiya T, Nishikawa T, Watanabe N, Ichikawa T, Kaneko M, Okubo S, Yokota H, Omata M, Fujiwara K, Yatomi Y. Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats. FEBS Letters 2007;581:1631-4. [DOI: 10.1016/j.febslet.2007.03.029] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
2 Arni D, Gumy-Pause F, Ansari M, Kremer Hovinga JA, McLin VA. Successful liver transplantation in a child with acute-on-chronic liver failure and acquired thrombotic thrombocytopenic purpura. Liver Transpl 2015;21:704-6. [PMID: 25727917 DOI: 10.1002/lt.24096] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Matsumoto M, Kawa K, Uemura M, Kato S, Ishizashi H, Isonishi A, Yagi H, Park YD, Takeshima Y, Kosaka Y. Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transplant. 2007;40:251-259. [PMID: 17549054 DOI: 10.1038/sj.bmt.1705724] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
4 Ko S, Chisuwa H, Matsumoto M, Fujimura Y, Okano E, Nakajima Y. Relevance of ADAMTS13 to liver transplantation and surgery. World J Hepatol 2015; 7(13): 1772-1781 [PMID: 26167250 DOI: 10.4254/wjh.v7.i13.1772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
5 Honda M, Yamamoto H, Hayashida S, Suda H, Ohya Y, Lee KJ, Takeichi T, Asonuma K, Inomata Y. Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients. Pediatr Transplant 2011;15:601-5. [PMID: 21790916 DOI: 10.1111/j.1399-3046.2011.01533.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Banno F, Miyata T. Biology of an Antithrombotic Factor—ADAMTS13. In: Tanaka K, Davie EW, Ikeda Y, Iwanaga S, Saito H, Sueishi K, editors. Recent Advances in Thrombosis and Hemostasis 2008. Tokyo: Springer Japan; 2008. pp. 162-76. [DOI: 10.1007/978-4-431-78847-8_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Pereboom IT, Adelmeijer J, van Leeuwen Y, Hendriks HG, Porte RJ, Lisman T. Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transplant. 2009;9:1189-1196. [PMID: 19422343 DOI: 10.1111/j.1600-6143.2009.02621.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 49] [Article Influence: 4.4] [Reference Citation Analysis]
8 Nakanuma S, Miyashita T, Hayashi H, Ohbatake Y, Takamura H, Okazaki M, Yamaguchi T, Sakai S, Makino I, Oyama K, Tajima H, Ninomiya I, Fushida S, Ohta T. Von Willebrand Factor Deposition and ADAMTS-13 Consumption in Allograft Tissue of Thrombotic Microangiopathy-like Disorder After Living Donor Liver Transplantation: A Case Report. Transplant Proc 2017;49:1596-603. [PMID: 28651806 DOI: 10.1016/j.transproceed.2017.02.047] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
9 Wong SL, Goverman J, Staudinger C, Wagner DD. Recombinant human ADAMTS13 treatment and anti-NET strategies enhance skin allograft survival in mice. Am J Transplant 2020;20:1162-9. [PMID: 31730284 DOI: 10.1111/ajt.15703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
10 Nobuoka Y, Wada H, Mizuno S, Kishiwada M, Usui M, Sakurai H, Tabata M, Kobayashi T, Nobori T, Uemoto S, Isaji S. Prolonged thrombocytopenia after living donor liver transplantation is a strong prognostic predictor irrespective of splenectomy: the significance of ADAMTS13 and graft function [corrected]. Int J Hematol 2014;99:418-28. [PMID: 24595551 DOI: 10.1007/s12185-014-1543-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, Katayama N, Uemoto S, Ishizashi H, Matsumoto M, Fujimura Y, Isaji S. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009;124:541-545. [PMID: 19423151 DOI: 10.1016/j.thromres.2009.03.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
12 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Int J Hepatol 2011;2011:759047. [PMID: 21994870 DOI: 10.4061/2011/759047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
13 Tatsumi K, Ohashi K, Taminishi S, Sakurai Y, Ogiwara K, Yoshioka A, Okano T, Shima M. Regulation of coagulation factors during liver regeneration in mice: Mechanism of factor VIII elevation in plasma. Thrombosis Research 2011;128:54-61. [DOI: 10.1016/j.thromres.2011.01.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
14 Ishikawa M, Uemura M, Matsuyama T, Matsumoto M, Ishizashi H, Kato S, Morioka C, Fujimoto M, Kojima H, Yoshiji H. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcohol Clin Exp Res. 2010;34 Suppl 1:S25-S33. [PMID: 19094193 DOI: 10.1111/j.1530-0277.2008.00850.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
15 Morioka C, Uemura M, Matsuyama T, Matsumoto M, Kato S, Ishikawa M, Ishizashi H, Fujimoto M, Sawai M, Yoshida M, Mitoro A, Yamao J, Tsujimoto T, Yoshiji H, Urizono Y, Hata M, Nishino K, Okuchi K, Fujimura Y, Fukui H. Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis. Scandinavian Journal of Gastroenterology 2009;43:1387-96. [DOI: 10.1080/00365520802179933] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
16 Takaya H, Uemura M, Fujimura Y, Matsumoto M, Matsuyama T, Kato S, Morioka C, Ishizashi H, Hori Y, Fujimoto M, Tsujimoto T, Kawaratani H, Toyohara M, Kurumatani N, Fukui H. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. Hepatol Res 2012;42:459-72. [PMID: 22292786 DOI: 10.1111/j.1872-034X.2011.00950.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
17 Matsushita T, Saito H. Hemostasis in chronic liver disease. J Thromb Haemost 2006;4:2066-7. [DOI: 10.1111/j.1538-7836.2006.02103.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
18 Mizuno S, Wada H, Hamada T, Nobuoka Y, Tabata M, Nobori T, Isaji S. Lethal hepatic infarction following plasma exchange in living donor liver transplant patients. Transpl Int 2011;24:e57-8. [PMID: 21382102 DOI: 10.1111/j.1432-2277.2011.01244.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
19 Rangarajan S, Kessler C, Aledort L. The clinical implications of ADAMTS13 function: the perspectives of haemostaseologists. Thromb Res 2013;132:403-7. [PMID: 24050828 DOI: 10.1016/j.thromres.2013.07.027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Takahashi N, Wada H, Usui M, Kobayashi T, Habe-Ito N, Matsumoto T, Uemoto S, Nobori T, Isaji S. Behavior of ADAMTS13 and Von Willebrand factor levels in patients after living donor liver transplantation. Thromb Res 2013;131:225-9. [PMID: 23266519 DOI: 10.1016/j.thromres.2012.12.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
21 Duquenne L, Balbeur S, Everard E, Reding R, Eeckhoudt S, Brichard B, Godefroid N, Derycke E, Komuta M, Scheers I, Smets F, Sokal E, Stéphenne X. vWFpp/ADAMTS13 ratio is a useful marker of postliver transplantation thrombotic microangiopathy: A pediatric case report. Clin Case Rep 2020;8:41-6. [PMID: 31998483 DOI: 10.1002/ccr3.2495] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Hugenholtz GCG, Ruitenbeek K, Adelmeijer J, Pereboom ITA, Meijers JCM, van der Bij W, Porte RJ, Erasmus ME, Lisman T. Development of a Hyperactive Primary Hemostatic System During Off-Pump Lung Transplantation Resulting From an Unbalance Between von Willebrand Factor and Its Cleaving Protease ADAMTS13: Primary Hemostasis in Lung Transplantation. American Journal of Transplantation 2015;15:1958-66. [DOI: 10.1111/ajt.13225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Werner MJM, de Meijer VE, Adelmeijer J, de Kleine RHJ, Scheenstra R, Bontemps STH, Reyntjens KMEM, Hulscher JBF, Lisman T, Porte RJ. Evidence for a rebalanced hemostatic system in pediatric liver transplantation: A prospective cohort study. Am J Transplant 2020;20:1384-92. [PMID: 31841272 DOI: 10.1111/ajt.15748] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
24 Mori S, Park MS, Kim H, Choi Y, Hong G, Yi NJ, Lee KW, Suh KS. Dysfunction in Patients With Small-for-Size Grafts After Living Donor Liver Transplantation. Int Surg. 2015;100:524-530. [PMID: 25785339 DOI: 10.9738/intsurg-d-14-00016.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Verbiest A, Pirenne J, Dierickx D. De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Reviews 2014;28:269-79. [DOI: 10.1016/j.blre.2014.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
26 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91:20-29. [PMID: 20054668 DOI: 10.1007/s12185-009-0481-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]